kanamycin a has been researched along with niacin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| NOSAKA, Y | 1 |
| BROUET, G; MARCHE, J | 1 |
| DHAR, S | 1 |
3 review(s) available for kanamycin a and niacin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[ON THE HEARING DISTURBANCE DUE TO STREPTOMYCIN AND KANAMYCIN AND THE MEASURES].
Topics: Adenosine Triphosphate; Dimercaprol; Flavin-Adenine Dinucleotide; Hearing Disorders; Humans; Kanamycin; Niacin; Nicotinic Acids; Pantothenic Acid; Riboflavin; Streptomycin; Thiamine; Thioctic Acid; Toxicology; Vitamin A; Vitamin B 12; Vitamin D; Vitamin K; Vitamins | 1963 |
[COMPLICATIONS OF A METABOLIC AND ENDOCRINE NATURE PRODUCED BY ANTIBACILLARY CHEMOTHERAPY].
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Avitaminosis; Cycloserine; Endocrinology; Ethionamide; Isoniazid; Kanamycin; Metabolic Diseases; Niacin; Niacinamide; Pyrazinamide; Streptomycin; Sulfones; Thiosemicarbazones; Toxicology; Viomycin; Vitamin B 6 Deficiency | 1964 |
4 other study(ies) available for kanamycin a and niacin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
PULMONARY MYCOBACTERIOSIS.
Topics: Cycloserine; Diagnosis; Drug Resistance; Drug Resistance, Microbial; Drug Therapy; Epidemiology; Humans; Kanamycin; Lung Diseases; Mycobacterium Infections; Niacin; Niacinamide; Thiosemicarbazones; Tuberculin Test | 1964 |